These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 4054835)

  • 1. Prolactin. International symposium on clinical endocrinology. Paris, May 18-19, 1984.
    Horm Res; 1985; 22(3):133-252. PubMed ID: 4054835
    [No Abstract]   [Full Text] [Related]  

  • 2. Hyperprolactinemia: a 12-year retrospective study at gynecologic endocrinology unit, Siriraj Hospital.
    Saejong R; Dangrat C; Techatrisak K; Angsuwatthana S; Rattanachaiyanont M; Tanmahasamut P
    J Med Assoc Thai; 2013 Oct; 96(10):1247-56. PubMed ID: 24350404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperprolactinemia diagnostics--dilemmas over optimal selection of prolactinemia time points.
    Szosland K; Stasiak M; Lewiński A
    Ann Agric Environ Med; 2015; 22(2):332-7. PubMed ID: 26094534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Is the assessment of biological activity of prolactin essential in the diagnosis of hyperprolactinemia?].
    Kostrzak A; Warenik-Szymankiewicz A; Meczekalski B
    Pol Merkur Lekarski; 2010 May; 28(167):359-61. PubMed ID: 20568397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Luteal phase hyperprolactinemia.
    Falk RJ; Anderson L
    Int J Fertil Menopausal Stud; 1994; 39(5):272-7. PubMed ID: 7820160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-induced hyperprolactinemia.
    Bandyopadhyay P
    Drugs Today (Barc); 2006 Feb; 42(2):103-19. PubMed ID: 16541187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antipsychotic-drug-induced hyperprolactinemia: physiopathology, clinical features and guidance].
    Besnard I; Auclair V; Callery G; Gabriel-Bordenave C; Roberge C
    Encephale; 2014 Feb; 40(1):86-94. PubMed ID: 23928066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Heterogeneity of immunoreactive prolactin in hyperprolactinemia of various origin].
    Bulatov AA; Makarovskaia EE; Dzeranova LK; Smirnova NB; Chernogolov VA; Marova EI; Mel'nichenko GA; Dedov II
    Probl Endokrinol (Mosk); 1992; 38(6):13-6. PubMed ID: 1302839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of psychotropic-induced hyperprolactinemia.
    Marken PA; Haykal RF; Fisher JN
    Clin Pharm; 1992 Oct; 11(10):851-6. PubMed ID: 1341991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethanol induces hyperprolactinemia by increasing prolactin release and lactotrope growth in female rats.
    De A; Boyadjieva N; Oomizu S; Sarkar DK
    Alcohol Clin Exp Res; 2002 Sep; 26(9):1420-9. PubMed ID: 12351938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-prolactin autoantibodies in systemic lupus erythematosus patients with associated hyperprolactinemia.
    Leaños A; Pascoe D; Fraga A; Blanco-Favela F
    Lupus; 1998; 7(6):398-403. PubMed ID: 9736323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Technology insight: measuring prolactin in clinical samples.
    Smith TP; Kavanagh L; Healy ML; McKenna TJ
    Nat Clin Pract Endocrinol Metab; 2007 Mar; 3(3):279-89. PubMed ID: 17315036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperprolactinemia is not associated with hyperestrogenism in noncycling African elephants (Loxodonta africana).
    Prado-Oviedo NA; Malloy EJ; Deng X; Brown JL
    Gen Comp Endocrinol; 2013 Aug; 189():7-14. PubMed ID: 23623777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macroprolactinemia in a patient with infertility and hyperprolactinemia.
    Khandwala HM
    South Med J; 2006 Nov; 99(11):1282-4. PubMed ID: 17195425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defective dopaminergic regulation of prolactin secretion in patients with hyperprolactinemia.
    Serri O; Beauregard H; Somma M; Comtois R; Jilwan N; Hardy J
    Clin Invest Med; 1988 Dec; 11(6):387-91. PubMed ID: 3229037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjunctive aripiprazole in the treatment of risperidone-induced hyperprolactinemia: A randomized, double-blind, placebo-controlled, dose-response study.
    Chen JX; Su YA; Bian QT; Wei LH; Zhang RZ; Liu YH; Correll C; Soares JC; Yang FD; Wang SL; Zhang XY
    Psychoneuroendocrinology; 2015 Aug; 58():130-40. PubMed ID: 25981348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of macroprolactinemia in hyperprolactinemia.
    Kasum M; Pavičić-Baldani D; Stanić P; Orešković S; Sarić JM; Blajić J; Juras J
    Eur J Obstet Gynecol Reprod Biol; 2014 Dec; 183():28-32. PubMed ID: 25461348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Detection and treatment of hyperprolactinemia in male infertility].
    Rogoza A; Mierzejewski W; Puzio M
    Ginekol Pol; 1994 Feb; 65(2):75-9. PubMed ID: 8070714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of hyperprolactinemia on prolactin and LH pulsatile pattern in female rats.
    Lafuente A; Marcó J; Esquifino AI
    Rev Esp Fisiol; 1992 Dec; 48(4):291-6. PubMed ID: 1302899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pituitary response profile following metoclopramide administration in women with different forms of hyperprolactinemia.
    Espinós JJ; Vanrell C; Gich I; Urgell E; Calaf J
    Gynecol Endocrinol; 2017 Feb; 33(2):148-151. PubMed ID: 27841032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.